tion licensing.
In this paper, we show that the cells with a hypomorcombination of the loxP sites flanking the NEO gene excised the NEO cassette, made the cells susceptible phic mutation in human ORC2 survive with only a slight prolongation of the G1 phase of the cell cycle. They do to G418, and left a loxP site in place of most of exon3 in the allele called ⌬-ORC2. (Figure 1C ; ⌬/ϩ). not permit EBNA1-dependent replication of episomes from oriP, but this replication is restored upon expresThe second allele of ORC2 was targeted with the same vector followed by G418 selection. Retargeting of the sion of wild-type Orc2 in these cells. Orc2 in cells is specifically associated with oriP and coimmunoprecipiloxP marked allele (⌬) recreates the Ϫ allele in cells called Ϫ/ϩ ( Figure 1C ). PCR screening of genomic DNA tates with EBNA1. Finally, cotransfection with geminin suppresses replication from oriP and this is rescued with the indicated primers produces a 352 bp product from the ϩ allele that is cut by EcoRI into fragments of by overexpression of Cdt1. Taken together, this data suggests that ORC and other human initiation factors 204 and 148 bp. Targeting of the wild-type ORC2 allele, on the other hand, creates the desired cell-line (⌬/Ϫ) are required for replication from oriP. This is demonstration of the use of eukaryotic replication proteins in the ( Figure 1C ). PCR screening produces a 313 bp product from the ⌬ allele that is cut by EcoRI into fragments of initiation of DNA replication from a viral origin of replication. The result concurrently identifies a novel means by 204 and 109 bp. PCR analysis identified 8.8% of the G418-resistant clones as ⌬/Ϫ mutants at the ORC2 lowhich to inhibit latent infection of Epstein Barr virus for therapeutic purposes. cus ( Figure 1D , ⌬/Ϫ).
The ⌬-ORC2 Allele Produces a Low Level Results of an N Terminally Truncated Orc2 Protein
In a conventional gene deletion experiment, transcripMutation of ORC2 Homologous recombination was used to replace the tion and polyadenylation of the drug resistance cassettes inserted in the two alleles of the target gene prethird exon of ORC2 (encoding the initiator ATG) in HCT116 colon carcinoma cells with a Neomycin phosvents residual expression of the latter. In the strategy employed here, however, only a loxP site is left in the photransferase (NEO) gene ( Figure 1A ). ORC2 ϩ/Ϫ clones were identified in 2%-3% of G418-resistant colomiddle of exon 3 in the ⌬ allele. Although the initiator ATG is removed, low levels of a variant ORC2 mRNA nies by Southern blotting ( Figure 1B) . Cre-mediated re- produced by read-through transcription or alternative antibody and coimmunoprecipitated with Orc3, supporting the hypothesis that it is derived from the ⌬-ORC2 splicing could express an N terminally deleted Orc2 protein from methionine-74 encoded by exon 4. Although locus ( Figure 2D ). an ␣-Orc2 antibody did not recognize the full-length 72 kDa Orc2 protein in the ⌬/Ϫ cells (Figure 2A) , an Orc2-The Hypomorphic Mutation in ORC2 Prolongs related polypeptide of 68 kDa was detected when 10 G1 Phase of the Cell Cycle times more cell lysate was analyzed ( Figure 2B ). BeThe proliferation rate of the ORC2 ⌬/Ϫ cells was decause the 68 kDa protein (⌬Orc2) was seen only in cells creased by 30% (doubling time 43 hr versus 33.5 hr with the ⌬ORC2 allele, the polypeptide was most likely in ORC2 ϩ/ϩ or ϩ/Ϫ cells) ( Figure 3A ). There was no the product of the loxP-marked ⌬-ORC2 locus.
increase in apoptosis or senescence in the ⌬/Ϫ cells (data not shown). FACS to measure the DNA content of asynchronously growing cells indicated a moderate Effect of the Hypomorphic Mutation in ORC2 on the Other ORC Subunits increase in the G1 phase population in the ⌬/Ϫ cells (Table 1) The slight differences between the results of these assays likely reflect the fact that different parameters levels in the ⌬/Ϫ cells, providing a positive control for chromatin recovery. We also show that the 68 kDa proare being measured. For example, the MTT assay in Figure 3A measures the metabolic activity of cells, while tein in ⌬/Ϫ cells was immunoprecipitated by anti-Orc2 mune serum, and analyzed by PCR for four regions of the Quantitation of the DpnI-resistant DNA in the blots (Figplasmid simultaneously. The four regions of the plasmid ure 5C) showed that replication was decreased to less were amplified by PCR using DNA from de-cross-linked than 10% in the ⌬/Ϫ cells compared to WT cells, sugchromatin (lanes 7-9). The results indicate that chromagesting that ORC was necessary for efficient replication tin containing the DS region of the plasmid was specififrom oriP. As in the stable replication assay, the fact cally precipitated by antibodies against Orc2 (lanes 1-2), that the replication of the oriP-containing plasmids was as well as EBNA-1 (lanes 5-6), but not by nonimmune reduced by 90% while the proliferation rate between serum (lanes 3-4). The nonimmune sera used for this ⌬/Ϫ and WT cells differs only by 50% also strongly experiment included antibodies against a splicing facsuggests that the inability of the oriP plasmid to replicate tor, Upf1, and against an EBV-encoded protein, LMP-2. cannot be attributed to the slower growth rate of the The data indicate that Orc2, and by extension ORC, is ⌬/Ϫ cells. and Newlon, 1993). We show that mammalian chromo-somes could replicate normally with less than 25% of that geminin and agents that mimic the action of geminin the normal complement of chromatin-bound replication could cure human cells of latent EBV infection. We beinitiator proteins. It should be noted, however, that allieve that geminin-based therapeutics would have conthough we failed to find any deficit in origin firing, this siderable advantages over other antiviral agents that may be due to the specific origins chosen for analysis.
inhibit DNA replication. Geminin would be unique among We cannot completely rule out the possibility that fewer antiviral agents in its ability to inhibit the initiation of origins fire in the ⌬/Ϫ cells compared to the WT cells.
DNA replication but not elongation. Since episomes conIn contrast to the minimal effects on chromosomal tain only one origin of replication while chromosomes DNA replication, we provide clear evidence that cellular contain multiple origins (not all of which are necessary Orc2 is necessary for replication from oriP of EBV. The for cell survival), it is likely that viral episomes would be extreme sensitivity of the oriP-dependent plasmids to far more sensitive to geminin-based drugs that specifithe ORC2 mutation could be because an episome with cally target initiation. This idea is supported by the fact one origin of replication is more sensitive to partial inhithat overexpression of geminin has only a minor effect bition of replication initiation than a larger chromosome on cell cycle progression of mammalian cells (data not with multiple origins. EBNA1 and oriP are still essential shown), whereas viral replication is strongly inhibited. prophylactics. Geminin-based preventive therapy can helps recruit ORC to oriP, recruitment of ORC to cellular be used to eliminate latently infected cells in patients chromosomal origins of replication might also be depenbefore they become immunosuppressed (due to prodent on sequence-specific DNA binding factors. Such gression of AIDS, posttransplant therapy, or therapy of indirect recruitment of mammalian ORC to chromatin autoimmune disease), to prevent the subsequent develby diverse sequence specific factors might explain why opment of malignancy when immunosuppression does it has been so difficult to find a single DNA sequence set in. Future experiments will explore these possibilities that acts as a replicator in mammalian chromosomal as well as examine whether ORC is required for lytic origins of replication.
infections of EBV and other herpesviruses. EBV lacks a Replication licensing is a mechanism by which cells virally encoded replicative helicase. Therefore, as with ensure that chromosomal origins fire once and only once replication from oriP, lytic replication from oriLyt might per cell cycle. EBV chromosomes in latently infected be dependent on the MCM helicase and be susceptible cells also replicate once and only once per cell cycle, to geminin. In addition, we will test whether ORC and but the mechanism for this regulation was unclear. 
